#USA #Precision Medicine #Studio City #EndoDNA #BIOS platform

EndoDNA Launches BIOS: Transforming Genetic Data Into Clinical Intelligence

In a significant advancement for the field of precision medicine, EndoDNA has launched BIOS, a groundbreaking clinical decision-support platform designed for healthcare practitioners. This innovative tool replaces the company's previous platform, myDNALive, and offers a more dynamic and integrated approach to utilizing genetic data.

A Shift from Static Reports to Adaptive Intelligence

Traditional genetic tests provided static, one-time reports that often left clinicians with more questions than answers. With BIOS, EndoDNA aims to bridge that gap. The platform features an adaptive dashboard that integrates various data points, including genomics, biomarkers, lifestyle factors, and patient symptoms, offering practitioners a comprehensive view of each individual's health over time. Len May, the Founder and CEO of EndoDNA, emphasizes this transition, stating, "Most genetic platforms stop at information. BIOS was built to answer the question clinicians are really asking: 'Now what?'"

By transforming complex biological data into actionable clinical insights, BIOS empowers practitioners to make informed decisions with greater clarity and consistency. The platform's design focuses on interconnected biological pathways rather than isolated genetic variations, providing a holistic understanding of a patient's biology.

Comprehensive Analysis Across Biological Pathways

BIOS leverages about 1 million validated genetic variants distributed across 21 biological pathway systems. This includes analysis related to:
1. Hormone metabolism and metabolic signaling
2. Inflammation and stress responses
3. Regulation of neurotransmitters and cognitive functions

These pathways are meticulously curated, with 214 pathways continuously updated to deliver actionable insights in real time.

Four Connected Memory Networks for Holistic Patient Profiles

One of the standout features of BIOS is its unique approach to patient data analysis. Instead of examining a single data point on its own, BIOS employs four connected memory networks to create a more nuanced picture of each patient:

• - World: Integrates population-level genomic data from various biobanks and genomic repositories.
• - Experience: Utilizes aggregated case histories from practitioners to identify effective treatment strategies for similar patients.
• - Opinion: Incorporates clinical notes and personalized adjustments made by practitioners to refine recommendations.
• - Observation: Monitors patient-reported outcomes and biomarker trends over time to enhance ongoing care.

With a HIPAA-compliant interface, practitioners can easily order DNA tests and access specialized reports across various categories, such as regenerative health and hormone optimization. With this comprehensive framework, BIOS aims to facilitate better patient outcomes and foster improved patient engagement.

A Proven Foundation for Precision Medicine

EndoDNA has established itself as a reputable player in the healthcare sector, servicing over 10,000 patients across more than nine countries through its accredited laboratories. The company prides itself on a remarkable 99.6% genotyping accuracy rate attributed to its advanced sequencing technologies. Moreover, with over 10 patents filed, including proprietary methodologies for analyzing the endocannabinoid system, EndoDNA is at the forefront of precision health solutions.

As of now, BIOS is available to licensed healthcare practitioners across the globe, signifying a transformative step in how genetic data can be utilized to inform clinical decisions.

Conclusion

With the launch of BIOS, EndoDNA is not just enhancing the way genetic data is interpreted; it is setting a new standard for how healthcare providers can engage with and utilize that information to deliver personalized care. This innovation has the potential to reshape the landscape of precision medicine, addressing the pressing needs of clinicians and patients alike. By turning genetic data into strategic clinical intelligence, EndoDNA is ensuring a brighter, more informed future in healthcare.